Finance Watch: Three New Funds Bring $1.6bn-Plus For Biopharma Firms Globally
VC Financings Pick Up Pace Ahead Of JPM
Private Company Edition: TCGX raises $1bn for its second fund, Goldman Sachs’ first fund totals $650m and Panlin’s biopharma fund grows. Also, Apollo’s series C increases to $260m, Avistone closes a $140m series B, OnCusp raises a $100m series A and HI-Bio grabs $95m in series B cash.
